00399 領航醫藥生物科技
按盤價 
0.510 +0.050 (+10.870%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 15/08/2025 | 毛裕民 | 1201(L) | -27,770,810(L) | 1,643,945,055(L) | 76.71 | |
| 13/08/2025 | 毛裕民 | 1201(L) | -16,800,000(L) | 1,671,715,865(L) | 78.01 | |
| 31/07/2025 | Extrawell Pharmaceutical Holdings Limited | 1213(L) | 286,000,000(L) | 13.35 | ||
| 31/07/2025 | 毛裕民 | 1303(L) | 148,514,851(L) | 1,688,515,865(L) | 78.79 | |
| 30/07/2025 | 毛裕民 | 1201(L) | -13,000,000(L) | 1,688,515,865(L) | 84.66 | |
| 30/07/2025 | 周耀庭 | 1201(L) | -20,000,000(L) | 282,509,900(L) | 14.16 | |
| 22/07/2025 | 毛裕民 | 1201(L) | 20,000,000(L) | 1,701,515,865(L) | 85.32 | |
| 21/07/2025 | 周耀庭 | 1201(L) | -31,290,000(L) | 302,509,900(L) | 15.16 | |
| 21/07/2025 | 毛裕民 | 1201(L) | -14,000,000(L) | 1,701,515,865(L) | 85.32 | |
| 15/07/2025 | Extrawell Pharmaceutical Holdings Limited | 1213(L) | 286,000,000(L) | 14.34 | ||
| 15/07/2025 | 周耀庭 | 1201(L) | -15,500,000(L) | 333,799,900(L) | 16.73 | |
| 15/07/2025 | 周耀庭 | 1303(L) | 99,009,900(L) | 349,299,900(L) | 17.51 | |
| 14/07/2025 | 周耀庭 | 11031(L) | +99,009,900(L) | 349,299,900(L) | 18.92 | |
| 14/07/2025 | 毛裕民 | 1201(L) | -148,514,852(L) | 1,715,515,865(L) | 92.94 | |
| 11/07/2025 | 周耀庭 | 1201(L) | -35,695,000(L) | 250,290,000(L) | 13.56 | |
| 09/07/2025 | 毛裕民 | 1201(L) | -43,300,000(L) | 1,864,030,717(L) | 100.98 | |
| 04/07/2025 | 周耀庭 | 1201(L) | -17,975,000(L) | 285,985,000(L) | 15.49 | |
| 23/06/2025 | Extrawell Pharmaceutical Holdings Limited | 1213(L) | 286,000,000(L) | 15.49 | ||
| 23/06/2025 | 周耀庭 | 1201(L) | -22,055,000(L) | 303,960,000(L) | 16.68 | |
| 21/05/2025 | 周耀庭 | 1201(L) | -19,615,000(L) | 326,015,000(L) | 17.89 | |
| 15/04/2025 | 周耀庭 | 1201(L) | -18,725,000(L) | 345,630,000(L) | 18.96 | |
| 24/01/2025 | 毛裕民 | 1201(L) | -10,000,000(L) | 1,907,330,717(L) | 104.67 | |
| 02/01/2025 | 毛裕民 | 1201(L) | -10,000,000(L) | 1,917,330,717(L) | 105.22 | |
| 30/12/2024 | 周耀庭 | 1201(L) | -3,695,000(L) | 364,355,000(L) | 20.00 | |
| 25/11/2024 | 毛裕民 | 1201(L) | -30,000,000(L) | 1,927,330,717(L) | 105.77 | |
| 20/11/2024 | 周耀庭 | 1201(L) | -38,150,000(L) | 368,050,000(L) | 20.20 | |
| 07/10/2024 | 周耀庭 | 1201(L) | -22,400,000(L) | 406,200,000(L) | 22.29 | |
| 11/09/2024 | Extrawell Pharmaceutical Holdings Limited | 1213(L) | 286,000,000(L) | 15.70 | ||
| 10/09/2024 | 毛裕民 | 1303(L) | 99,009,900(L) | 1,957,330,717(L) | 107.42 | |
| 08/08/2024 | 毛裕民 | 1201(L) | -60,000,000(L) | 1,960,330,717(L) | 113.76 | |
| 21/06/2024 | 毛裕民 | 1113(L) | 2,020,330,717(L) | 117.24 | ||
| 10/01/2024 | 毛裕民 | 1303(L) | 55,000,000(L) | 1,129,970,810(L) | 65.57 | |
| 10/01/2024 | Extrawell Pharmaceutical Holdings Limited | 1213(L) | 286,000,000(L) | 16.60 | ||
| 08/01/2024 | 毛裕民 | 1201(L) | -50,000,000(L) | 1,129,970,810(L) | 67.74 | |
| 08/01/2024 | 毛裕民 | 1201(L) | -50,000,000(L) | 1,129,970,810(L) | 67.74 | |
| 08/01/2024 | 周耀庭 | 1101(L) | +50,000,000(L) | 428,600,000(L) | 25.69 | |
| 05/01/2024 | 毛裕民 | 1303(L) | 99,000,000(L) | 1,179,970,810(L) | 70.73 | |
| 05/01/2024 | Extrawell Pharmaceutical Holdings Limited | 1213(L) | 286,000,000(L) | 17.14 | ||
| 02/01/2024 | 周耀庭 | 1101(L) | +50,000,000(L) | 378,600,000(L) | 24.13 | |
| 02/01/2024 | 毛裕民 | 1201(L) | -50,000,000(L) | 1,179,970,810(L) | 75.19 | |
| 1 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 22/08/2025 17:59 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
